Thursday, 12 July 2018

Zogenix's treatment for rare epilepsy meets advanced study goal

Zogenix Inc said on Thursday its drug to treat Dravet syndrome, a rare form of epilepsy, met the main goal of a late-stage trial.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)